Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04129515
Title NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Eric Wong, MD
Indications

melanoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST